High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism.
Level 5 - mechanism / opinion, no new human data
Preclinical animal experimental research with an observational human component; animal and mechanistic studies are Level 5.
PubMed 29507217 · doi:10.1073/pnas.1713837115
What was done
Researchers investigated the mechanism by which high salt intake influences metabolic dysfunction in mice, focusing on the aldose reductase-fructokinase pathway in the liver and hypothalamus, endogenous fructose production, leptin resistance, hyperphagia, obesity, insulin resistance, and fatty liver. They also evaluated whether high-salt diets predicted incident diabetes and nonalcoholic fatty liver disease in a healthy human population.
What was found
The abstract reports no numerical values, effect sizes, or confidence intervals. Qualitatively, high salt intake activated the aldose reductase-fructokinase pathway in mouse liver and hypothalamus, driving endogenous fructose production, leptin resistance, hyperphagia, obesity, insulin resistance, and fatty liver. High salt intake also predicted the development of diabetes and nonalcoholic fatty liver disease in the human population assessed.
Why it matters
These findings suggest a novel mechanistic pathway linking dietary salt intake to obesity and metabolic syndrome via endogenous fructose synthesis, highlighting dietary sodium reduction as a potential metabolic target.
Limits
The abstract provides no sample sizes, dietary sodium concentrations, exposure timeframes, or statistical estimates for either the rodent experiments or the human observational analysis. Rodent metabolic responses do not necessarily translate to humans, and the observational human findings cannot establish causality.
Cited by
- supports In animal experiments, high-salt intake leads to obesity and diabetes through endogenous fructose production, and blocking fructose metabolism prevents this high-salt-induced obesity.